Actively Recruiting
University of Illinois Chicago Multi-Ethnic Dilated Cardiomyopathy (DCM) Registry
Led by University of Illinois at Chicago · Updated on 2025-08-28
1500
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to understand how dilated cardiomyopathy (DCM), a serious heart condition where the heart cannot pump blood effectively, affects different racial and ethnic groups in the United States. The study focuses on minorities such as African American and Hispanic/Latino patients, who are more commonly affected and may experience more severe outcomes. Researchers want to find out if specific genes linked to DCM are more frequent in these groups and how medical, social, and financial challenges contribute to the disease's impact. Participants will join the UIC Multi-Ethnic DCM Biorepository, where their genetic information will be collected and analyzed to see how often certain gene variants appear across different races and ethnicities. The study will not involve treatments but will observe and record health data over time to assess the severity of DCM and its symptoms. The focus is on understanding how a person's environment and genetic background influence their heart condition. During the study, participants will provide consent and share health information, including completing questionnaires like the Minnesota Living with Heart Failure Questionnaire if they have or develop heart failure. Researchers will monitor genetic variants and symptom severity at multiple time points, such as 12, 24, and 60 months after enrollment or diagnosis. The study aims to help improve heart care equity by identifying factors that affect disease severity among ethnic minorities. Participation may last several years, with ongoing data collection and evaluation.
CONDITIONS
Brief Title
UIC Multi-Ethnic DCM Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Must be at least 18 years of age and be admitted to or seen at a UIH site.
- Must be willing and able to give written, informed consent.
You will not qualify if you...
- Adults who are unable to provide consent.
- Women who are pregnant at the baseline visit.
- Prisoners.
- Individuals who are not yet adults (infants, children, teenagers).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Baseline
Participants undergo assessments to identify genetic variants and evaluate disease severity.
1 visit (in-person)
Duration - Up to 60 months
Participants with heart failure or who develop heart failure complete digital symptom assessments over time.
Assessments at 12 months, 24 months, and 60 months after enrollment or new heart failure diagnosis
Trial Site Locations
Total: 1 location
1
University of Illinois Hospital & Health Sciences
Chicago, Illinois, United States, 60612
Actively Recruiting
Research Team
D
David Tofovic, M.D.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here